Antimicrobial & Biocontrol Agents Unit (AmBcAU), Laboratory for Phytobiochemistry and Medicinal Plants Studies, Department of Biochemistry, Faculty of Science, University of Yaoundé I, Yaoundé, Cameroon.
Department of Microbiology and Biotechnology, Division of Clinical and Biological Sciences, College of Pharmacy, Arab Academy for Science, Technology and Maritime Transport (AASTMT), Alexandria, Egypt.
Mycoses. 2022 Nov;65(11):989-1000. doi: 10.1111/myc.13483. Epub 2022 Jul 7.
Candida tropicalis is a human pathogenic yeast frequently isolated in Latin America and Asian-Pacific regions, although recent studies showed that it is also becoming increasingly widespread throughout several African and south-European countries. Nevertheless, relatively little is known about its global patterns of genetic variation as most of existing multilocus sequence typing (MLST) data come from Asia and there are no genotyped African isolates.
We report detailed genotyping data from a large set of C. tropicalis isolates recovered from different clinical sources in Italy, Egypt and Cameroon in order to expand the allele/genotype library of MLST database (https://pubmlst.org/ctropicalis), and to explore the genetic diversity in this species.
A total of 103 C. tropicalis isolates were genotyped using the MLST scheme developed for this species. All isolates were also tested for in vitro susceptibility to various antifungals to assess whether certain genotypes were associated with drug-resistance.
A total of 104 different alleles were detected across the MLST-loci investigated. The allelic diversity found at these loci resulted in 51 unique MLST genotypes of which 36 (70.6%) were novel. Global optimal eBURST analysis identified 18 clonal complexes (CCs) and confirm the existence of a specific Italian-cluster (CC36). Three CCs were also statistically associated with fluconazole resistance, which was elevated in Cameroon and Egypt. Our data show high genetic diversity in our isolates suggesting that the global population structure of C. tropicalis is still poorly understood. Moreover, its clinical impact in Italy, Egypt and Cameroon appears to be relevant and should be carefully considered.
热带假丝酵母是一种人源致病性酵母,常分离于拉丁美洲和亚太地区,但最近的研究表明,它在几个非洲和南欧国家也越来越普遍。然而,由于大多数现有的多位点序列分型(MLST)数据来自亚洲,而且没有经过基因分型的非洲分离株,因此对其全球遗传变异模式的了解相对较少。
我们报告了来自意大利、埃及和喀麦隆不同临床来源的大量热带假丝酵母分离株的详细基因分型数据,以扩展 MLST 数据库(https://pubmlst.org/ctropicalis)的等位基因/基因型库,并探索该物种的遗传多样性。
使用为该物种开发的 MLST 方案对 103 株热带假丝酵母进行了基因分型。还对所有分离株进行了体外抗真菌药物敏感性测试,以评估某些基因型是否与耐药性相关。
在所研究的 MLST 基因座中共检测到 104 个不同的等位基因。这些基因座的等位基因多样性导致了 51 个独特的 MLST 基因型,其中 36 个(70.6%)是新的。全球最优 eBURST 分析确定了 18 个克隆复合体(CC),并证实了意大利特定集群(CC36)的存在。三个 CC 也与氟康唑耐药性相关,在喀麦隆和埃及,氟康唑耐药性升高。我们的数据显示,我们的分离株具有很高的遗传多样性,这表明热带假丝酵母的全球种群结构仍未得到很好的理解。此外,它在意大利、埃及和喀麦隆的临床影响似乎很重要,应该谨慎考虑。